ZylexisThis page contains information on Zylexis for veterinary use.
The information provided typically includes the following:
- Zylexis Indications
- Warnings and cautions for Zylexis
- Direction and dosage information for Zylexis
ZylexisThis treatment applies to the following species:
Parapox Ovis Virus Immunomodulator
For use in healthy horses 4 months of age or older as an aid in reducing upper respiratory disease caused by equine herpesvirus types 1 and 4. Zylexis is an immunostimulant consisting of inactivated Parapox ovis virus.
Directions For Use
Aseptically rehydrate the freeze-dried component with the sterile diluent provided, shake well and administer 2 mL intramuscularly. Repeat the 2-mL dose on days 2 and 9 following the initial dose. Retreatment is recommended during subsequent disease episodes or prior to stress-inducing situations.
PrecautionsStore at 2°-8°C. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Do not vaccinate within 21 days before slaughter. In case of anaphylaxis, administer epinephrine or equivalent.
Mfd. by: Bayer A.G. Animal Division, D-50739 Cologne, Germany
Dist. by: Zoetis Inc., Kalamazoo, MI 49007
U.S. Permit No. 189C
5 x 1 dose vials of vaccine
Rehydrate to 2 ml
5 x 2 ml vials of sterile diluent
For use in horses only
NAC No.: 36902292
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Zylexis information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2014 North American Compendiums. Updated: 2014-07-28